GOLDMAN SACHS GROUP INC

Position in INSM — INSMED Inc

CIK 886982 NEW YORK, NY

Back to INSM Full portfolio

Position in INSM

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$150,321,937

-$3,819,534 QoQ

Shares Held

1,409,885

+49.6% QoQ

Ownership

0.646%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#29

of 665 holders

Holding Since

Mar 2020

26 quarters on record

Voting authority Sole 97% Shared 0% None 3%

Common Shares in INSM Over Time

Shares Held

Position Value (USD)

Derivatives in INSM

reported options exposure · as of Jun 30, 2026

CallValue

$8,934,756

CallShares

83,800

PutValue

$81,873,498

PutShares

767,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,040,380,016 across 360 Biotechnology names. INSM ranks #16 (1.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,481,761	$1,232,765,138
2	REGN	Regeneron Pharmaceuticals, Inc.	1,163,191	$725,296,113
3	ROIV	Roivant Sciences Ltd.	18,556,458	$656,713,046
4	TECH	BIO-TECHNE Corp	7,343,324	$518,805,838
5	RVMD	Revolution Medicines, Inc.	2,133,101	$399,487,154
6	MRNA	Moderna, Inc.	4,671,950	$327,176,656
7	TNGX	Tango Therapeutics, Inc.	9,980,620	$311,994,180
8	INCY	Incyte Corp	2,305,782	$261,383,446

All Filings in INSM

Export CSV

33 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$8,934,756	83,800	+43.2%	Call	Defined	2026-08-14
2026-06-30	$81,873,498	767,900	+220.0%	Put	Defined	2026-08-14
2026-06-30	$150,321,937	1,409,885	+49.6%	Shares	Defined	2026-08-14
2026-03-31	$154,141,471	942,646	-24.3%	Shares	Defined	2026-05-15
2025-12-31	$216,664,656	1,244,913	+50.1%	Shares	Defined	2026-03-25
2025-12-31	$10,181,340	58,500	-55.0%	Call	Defined	2026-03-25
2025-09-30	$119,429,939	829,317	-54.2%	Shares	Defined	2025-11-14
2025-09-30	$18,721,300	130,000	+30.0%	Call	Defined	2025-11-14
2025-06-30	$24,153,600	240,000	—	Put	Defined	2025-08-14
2025-06-30	$182,248,471	1,810,895	+29.1%	Shares	Defined	2025-08-14
2025-06-30	$10,064,000	100,000	+183.3%	Call	Defined	2025-08-14
2025-03-31	$107,005,954	1,402,621	-18.5%	Shares	Defined	2025-06-27
2024-12-31	$118,752,181	1,720,049	+23.5%	Shares	Defined	2025-02-11
2024-12-31	$2,437,112	35,300	—	Call	Defined	2025-02-11
2024-09-30	$101,692,577	1,393,049	+17.1%	Shares	Defined	2024-11-14
2024-06-30	$79,723,367	1,189,901	+57.9%	Shares	Defined	2024-08-13
2024-03-31	$20,445,437	753,610	-1.1%	Shares	Defined	2024-05-15
2023-12-31	$23,607,314	761,772	-11.8%	Shares	Defined	2024-05-14
2023-09-30	$21,803,828	863,518	+8.8%	Shares	Defined	2024-05-15
2023-06-30	$16,746,732	793,684	+41.3%	Shares	Defined	2024-05-14
2023-03-31	$9,578,621	561,796	-45.5%	Shares	Defined	2024-05-14
2022-12-31	$20,597,301	1,030,896	+18.3%	Shares	Defined	2024-05-14
2022-09-30	$18,765,152	871,177	+86.0%	Shares	Defined	2024-05-14
2022-06-30	$9,238,819	468,500	-15.9%	Shares	Defined	2024-05-14
2022-03-31	$13,088,982	556,978	+20.2%	Shares	Defined	2022-05-16
2021-12-31	$12,621,000	463,326	+91.3%	Shares	Defined	2022-02-17
2021-09-30	$6,669,856	242,188	-67.3%	Shares	Defined	2022-01-20
2021-06-30	$21,076,308	740,559	-24.4%	Shares	Defined	2021-08-13
2021-03-31	$33,369,466	979,726	-24.3%	Shares	Defined	2021-05-17
2020-12-31	$43,094,836	1,294,528	+28.5%	Shares	Defined	2021-02-12
2020-09-30	$32,376,164	1,007,348	+8.1%	Shares	Defined	2020-11-13
2020-06-30	$25,656,759	931,618	+21.6%	Shares	Defined	2020-08-12
2020-03-31	$12,276,462	765,843	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.